Literature DB >> 32410340

Surgical treatment of intestinal stricture in inflammatory bowel disease.

Helen M Mohan1, John C Coffey1,2.   

Abstract

Fibroblast infiltration and collagen deposition result in structural changes in the bowel wall, and lead to strictures in intestinal inflammatory disease. While strictures can also occur in other contexts, such as malignancy, this review focuses on the surgical treatment of stricture secondary to inflammatory bowel disease. Distinguishing between predominantly inflammation vs established fibrosis as the cause of a stricture can be challenging. While inflammatory strictures may be responsive to medication, predominantly fibrotic strictures usually need surgical intervention. Both endoluminal and extraluminal approaches are described in this review. Endoscopic dilatation of strictures is suitable for short-segment isolated small bowel strictures. Other options are to divide the stricture surgically but preserve the length, performing a strictureplasty or resecting the strictured segment. The mesentery is increasingly recognized as playing a role in stricture recurrence. In a relapsing-remitting disease such as Crohn's disease, the preservation of intestinal length is essential and balance is needed between this and a complete resection to reduce the risk of recurrence. Pre- and postoperative involvement of the multidisciplinary team is essential to improve outcomes in this challenging clinical scenario.
© 2020 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Crohn disease; inflammatory bowel diseases; mesentery; resection; stricture; strictureplasty

Mesh:

Year:  2020        PMID: 32410340     DOI: 10.1111/1751-2980.12880

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  5 in total

Review 1.  Impact of gastric and bowel surgery on gastrointestinal drug delivery.

Authors:  Susan Hua; Ephraem C Lye
Journal:  Drug Deliv Transl Res       Date:  2022-05-18       Impact factor: 4.617

2.  A systems biology analysis of protein-protein interaction of digestive disorders and Covid-19 virus based on comprehensive gene information.

Authors:  Arghavan Hosseinpouri; Mostafa Rezaei-Tavirani; Elham Gholizadeh; Reza Karbalaei
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2022

Review 3.  Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2.

Authors:  Samar A Antar; Mohamed A Saleh; Ahmed A Al-Karmalawy
Journal:  Life Sci       Date:  2022-10-07       Impact factor: 6.780

Review 4.  Prevention and Treatment of Stricturing Crohn's Disease - Perspectives and Challenges.

Authors:  Joseph Sleiman; Sara El Ouali; Taha Qazi; Benjamin Cohen; Scott R Steele; Mark E Baker; Florian Rieder
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2020-12-28       Impact factor: 3.869

Review 5.  Mechanism of fibrosis and stricture formation in Crohn's disease.

Authors:  Johannes Alfredsson; Mary Jo Wick
Journal:  Scand J Immunol       Date:  2020-12       Impact factor: 3.487

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.